NEW YORK, September 2, 2014 /PRNewswire/ --

BreedIT Corp., (OTCQB: BRDT) through its Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license holder and distributor of highly sophisticated agro-breeding solutions software for plant breeders and researchers, is pleased to announce that BreedIT Scientific Advisor Dr. Alan Shackelford has been featured in an interview by CEOLIVE.TV. The interview is scheduled to be published on Wednesday, September 3.

In the interview, Dr. Shackelford discusses many topics, including BreedIT's collaboration with Hebrew University of Jerusalem and BreedIT's unique position in the emerging marijuana industry as a company at the forefront of the technology that combines academia and practical experience to selectively produce targeted strains of cannabis with specific therapeutic implications. Dr. Shackelford also details why the location of BreedIT's subsidiary in Israel, often called the medical research capital of the world, is significant on a global scale to advance cannabis research on various levels. "I am very pleased that Dr. Shackelford participated in this interview as I think it is paramount to inform shareholders and all interested parties about the impact potential of BreedIT and its IDSS software and technology on the cannabis industry," commented Mr. Itschak Schrem, Chaiman of BreedIT Corp. "This is a proven technology developed by academic leaders that can shave years off the very onerous task of identifying and breeding specific traits into cannabis, whether for medicinal or industrial purposes. Dr. Shackelford's extensive clinical knowledge coupled with his deep understanding of the industry in general, delivers the message in a concise manner as to why what we are doing is so compelling."

About BreedIT Corp.

BreedIT Corp. (BRDT [http://finance.yahoo.com/q?s=brdt ]) http://www.brdt.us , through its Israeli subsidiary, BreedIT Ltd (http://www.ibreedit.com) , is the developer of highly sophisticated agro-breeding solutions for plant breeders and researchers. BreedIT's proven iBreedIT(R) - the Intelligent Decision Support System (IDSS) for breeders which was developed by a team consisting of among the world's leading breeding specialists for optimizing the breeding processes, services the plant breeding needs of corporations, research and government institutions. BreedIT's IDSS provides advanced solutions for generating and disseminating knowledge aimed at assisting breeders to plan, manage and analyze their breeding data and to perform research activities quickly and effectively. Founded in 2013, BreedIT Ltd has offices in New York, New York and in Rehovot, Israel.

Forward-Looking Statements:

This press release may contain forward-looking statements, including information about management's view of the Company's future expectations, plans and prospects, within the safe harbor provisions under The Private Securities Litigation Reform Act of 1995 (the "Act"). In particular, when used in the preceding discussion, the words "believes," "expects," "intends," "plans," "anticipates," or "may," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act, and are subject to the safe harbor created by the Act. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of the Company, its divisions and concepts to be materially different than those expressed or implied in such statements. These risk factors and others are included from time to time in documents the Company files with the Securities and Exchange Commission, including but not limited to, its Form 10-K, Form 10-Qs and Form 8-Ks. Other unknown or unpredictable factors also could have material adverse effects on the Company's future results. The forward-looking statements included in this press release are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by the Company. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated.*

BreedIt Corp's public filings may be viewed at http://www.sec.gov. 


        
        Contact:
        Lorin Cohen
        +1-720-319-7519

SOURCE BreedIT Corp